| |
F2
|
F3
|
F2 vs F3
|
|---|
|
n
|
Mean or ratio
|
SD
|
n
|
Mean or ratio
|
SD
|
T-test or Fisher’s exact test p
|
Age-adjusted
|
|---|
|
p
|
Mean differences (95% CI)
|
Odds ratios (95% CI)
|
|---|
|
Body mass index (BMI, kg/m2)
|
130
|
24.1
|
4.9
|
43
|
22.9
|
5
|
N.S.
|
N.S.
|
0.53 (− 1.3 to 2.4)
| |
|
Male
|
56
|
24.7
|
4.9
|
19
|
21.7
|
3.8
|
0.0018
|
N.S.
|
1.8 (− 1.0 to 4.7)
| |
|
Female
|
74
|
23.6
|
4.8
|
24
|
23.8
|
5.7
|
N.S.
|
N.A.
| | |
|
Waist circumference (cm)
|
119
|
85.2
|
13.6
|
39
|
83.6
|
13.7
|
N.S.
|
N.A.
| | |
|
Male
|
51
|
88.5
|
13.2
|
16
|
82.8
|
12.1
|
N.S.
|
N.A.
| | |
|
Female
|
68
|
82.6
|
13.5
|
23
|
84.2
|
14.9
|
N.S.
|
N.A.
| | |
|
Systolic blood pressure (mmHg)
|
144
|
125.3
|
16
|
45
|
131.6
|
18.2
|
0.026
|
N.S.
|
− 3.3 (− 9.4 to 2.7)
| |
|
Male
|
62
|
127.5
|
16.2
|
20
|
131.5
|
18.6
|
N.S.
|
N.A.
| | |
|
Female
|
82
|
123.5
|
15.8
|
25
|
131.7
|
18.3
|
0.031
|
N.S.
|
− 3.2 (− 10.8 to 4.3)
| |
|
Diastolic blood pressure (mmHg)
|
144
|
77.2
|
11.4
|
45
|
77.0
|
11.1
|
N.S.
|
N.A.
| | |
|
Male
|
62
|
80.4
|
10.9
|
20
|
77.1
|
9.7
|
N.S.
|
N.S.
|
− 0.3 (− 6.4 to 5.9)
| |
|
Female
|
82
|
74.8
|
11.3
|
25
|
77.0
|
12.4
|
N.S.
|
N.A.
| | |
|
Hypertension
|
144
|
0.271
| |
45
|
0.467
| |
0.017
|
N.S.
| |
0.6 (0.28 to 1.28)
|
|
Male
|
62
|
0.355
| |
20
|
0.450
| |
N.S.
|
N.A.
| | |
|
Female
|
82
|
0.207
| |
25
|
0.480
| |
0.011
|
N.S.
| |
0.47 (0.17 to 1.32)
|
|
Diabetes mellitus
|
144
|
0.160
| |
45
|
0.156
| |
N.S.
|
N.S.
| |
2.00 (0.77 to 5.65)
|
|
Male
|
62
|
0.190
| |
20
|
0.100
| |
N.S.
|
N.A.
| | |
|
Female
|
82
|
0.130
| |
25
|
0.200
| |
N.S.
|
N.S.
| |
1.20 (0.33 to 4.44)
|
|
High LDL-cholesterolemia
|
140
|
0.264
| |
44
|
0.364
| |
N.S.
|
N.S.
| |
0.85 (0.39 to 1.89)
|
|
Male
|
60
|
0.283
| |
19
|
0.211
| |
N.S.
|
N.A.
| | |
|
Female
|
80
|
0.250
| |
25
|
0.480
| |
0.045
|
N.S.
| |
0.46 (0.17 to 1.27)
|
|
Low HDL-cholesterolemia
|
139
|
0.209
| |
44
|
0.205
| |
N.S.
|
N.A
| | |
|
Male
|
59
|
0.322
| |
19
|
0.316
| |
N.S.
|
N.A
| | |
|
Female
|
80
|
0.125
| |
25
|
0.12
| |
N.S.
|
N.A
| | |
|
Hypertriglyceridemia
|
143
|
0.210
| |
44
|
0.205
| |
N.S.
|
N.A
| | |
|
Male
|
62
|
0.258
| |
19
|
0.158
| |
N.S.
|
N.A
| | |
|
Female
|
81
|
0.173
| |
25
|
0.240
| |
N.S.
|
N.A
| | |
|
Metabolic syndrome
|
115
|
0.209
| |
38
|
0.263
| |
N.S.
|
N.A.
| | |
|
Male
|
49
|
0.306
| |
15
|
0.200
| |
N.S.
|
N.A.
| | |
|
Female
|
66
|
0.136
| |
23
|
0.304
| |
N.S.
|
N.S.
| |
0.61 (0.17 to 2.13)
|
|
Prevalence of smoking
|
139
|
0.396
| |
40
|
0.125
| |
0.0011
|
0.0148*
| |
3.62 (1.29 to 10.4)
|
|
Male
|
61
|
0.541
| |
16
|
0.188
| |
0.013
|
N.A.
| | |
|
Female
|
78
|
0.282
| |
24
|
0.083
| |
N.S.
|
N.A.
| | |
|
Ratio of SBI and cerebral infarction
|
141
|
0.234
| |
44
|
0.477
| |
0.0039
|
N.S.
| |
1.06 (0.426 to 2.64)
|
- First, we used t-test in quantitative variables and Fisher’s exact test in qualitative variables between F2 and F3 groups without any adjustments. Next, Age-adjusted mean differences were estimated using ANCOVA and Odds ratios were calculated using logistic regression analysis. CI is an abbreviation of confidence interval. N.A. means not applicable. N.S. means not significant (p ≥ 0.05). * is significantly different (p < 0.05) between F2 group and F3 group by age-adjusted analysis
